Organisation: World Trade Organization

Featured in The Guide to Life Sciences: Key issues for senior life sciences executives 2024

The South African pharmaceutical industry has grown substantially in recent years, while patent legislation has undergone significant divergence. Effective enforcement, prosecution and launch-to-market strategies require a keen understanding of the country’s IP and regulatory frameworks. 

24 June 2024

The country has a high infringement claim success rate compared to its peers in Europe

15 March 2024

Only the parties’ Chinese counsel have been allowed access to the unredacted version of the ruling

15 January 2024

Disappointment with last year’s WTO agreement on suspending patent rights to secure covid-19 vaccine supplies has led campaigners to intensify calls for a new agreement that would include know-how

05 October 2023

Saturday Opinion: Disseminating covid diagnostics and therapeutics is critical, but attempting to do so via the TRIPS waiver extension is rife with unintended consequences

04 March 2023

These new patent pools, global litigation developments, and SEP policy changes will keep making waves in the New Year

21 December 2022

While WTO member states have expressed general sympathy for the goal to provide broad access to vaccine technology during the pandemic, Germany continues to favour patent protection over compulsory licensing.

16 November 2022

While final outcomes are still pending, outlook suggests strong IP policy impact

11 November 2022

As the European Commission simultaneously pursues a standardisation strategy, new SEP framework and DG Comp guidelines, Haris Tsilikas argues that any inconsistencies or contradictions in these efforts could damage the continent’s standards leadership

30 March 2022

Predictions from the IAM editorial team on what the next twelve months have in store

03 January 2022